Keywords
Radiation
Neoplasia
Oncology
Therapeutics
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To understand the profile of patients undergoing radiosurgery for the resection of intracranial tumors in a cancer treatment reference hospital in the western region of Paraná over the past 10 years. Methods: This is an observational, cross-sectional study that analyzed 33 electronic medical records of patients with intracranial tumors undergoing radiosurgery between 2013 and 2023 at the hospital in question. Results: Predominantly, female patients (57.6%) with a mean age of 55 years were identified. Metastatic lesions were more prevalent (66.6%), with breast and lung being the most commonly found primary tumor sites. Regarding the number of intracranial lesions presented, the majority of patients had only one intracranial lesion (78.8%). Among the studied patients, in 72.7% of cases, radiosurgery was used for lesion resection, being used minimally in the surgical setting. Finally, a preference for fractionated radiosurgery (69.8%) was noted, with an average of 5 doses of 5Gy each. Conclusion: The profile found was that of middle-aged women with only one metastatic intracranial lesion, treated with fractionated radiosurgery, which is in accordance with what is found in the literature. It is proposed to conduct further fragmented studies to better understand the data presented.
References
AIZER AA, et al. Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro Oncol, 2022; 24(10): 1613-1646.
AL-WASSIA RK e ISKANDERANI O. Stereotactic Radiosurgery (SRS) experience on brain metastases: a 3-year retrospective study at king abdulaziz university hospital. Saudi Journal of Biological Sciences, 2021; 28(9): 5042-5047.
BARNETT GH, et al. Stereotactic radiosurgery--an organized neurosurgery-sanctioned definition. J Neurosurg, 2007; 106(1): 1-5.
BRASIL, Ministério da Saúde. ABC do câncer: abordagens básicas para controle do câncer. 2020. Disponível em: https ://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document/livro_abc_6ed_0.pdf. Acessado em: 05 abr. 2023.
BRASIL, Ministério da Saúde. Estimativa 2023: Incidência de câncer no Brasil. 2022. Disponível em: https ://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2023.pdf. Acessado em: 05 abr. 2023.
BROWN PD, et al. Stereotactic Radiosurgery for Patients with “Radioresistant” Brain Metastases. Neurosurgery, 2008; 2: 790-801.
BROWN PD, et al. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA, 2016; 316(4): 401-409.
BROWN PD, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol, 2017; 18(8): 1049-1060.
CANTERAS MM. Radiocirurgia. Revista Neurociências, 2019; 13(4): 190-195.
CHEN WC, et al. Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases: A Systematic Review and Meta-analysis. JAMA Oncol, 2021; 7(7): 1033-1040.
FAG. Manual de normas para elaboração e apresentação de trabalhos acadêmicos. 2015. Disponível em: https ://www.fag.edu.br/novo/arquivos/academico-online/manual-de-normas-2015-22.pdf. Acessado em: 27 mar. 2023.
FEDORCSÁK I, et al. Agyi daganatos elváltozások sztereotaxiás besugárzása. Instituto Nacional de Mental, Neurológica e Neurocirurgia. Magyar Onkológia, 2024; 68: 53-59.
GOMES JG, et al. Tratamento das Metástases Cerebrais com Radiocirurgia. Jornal Brasileiro de Neurocirurgia, 2018; 25(3): 240-250.
HO AL, et al. National trends in inpatient admissions following stereotactic radiosurgery and the in-hospital patient outcomes in the United States from 1998 to 2011. Journal Of Radiosurgery And Sbrt, 2016; 4(3): 165-176.
JUSTINO PB, et al. Radiocirurgia e radioterapia estereotáxica: princípios e aplicações. Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery, 2004; 23(4): 163-170.
KONDZIOLKA D, et al. Long‐term survivors after gamma knife radiosurgery for brain metastases. Cancer, 2005; 104(12): 24784-2791.
LAPOINTE S, et al. Primary brain tumours in adults. The Lancet, 2018; 392(10145): 432-446.
LASSMAN A B e DEANGELIS LM. Brain metastases. Neurologic Clinics, 2003; 21(1): 1-23.
MAHAJAN A, et al. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol, 2017; 18(8): 1040-1048.
MASCARENHAS F, et al. A radiocirurgia estereotáxica em tumores benignos e malignos do sistema nervoso central. Acta Médica Portuguesa, 2005; 18: 45-60.
MUKHERJEE S. O imperador de todos os males. São Paulo: Companhia Das Letras, 2012; 6: 15-98.
PATEL KS, et. al. Applications of Stereotactic Radiosurgery in Neuro-Oncology. In: Handbook of Neuro-Oncology Neuroimaging. 2. ed. Cambridge: Academic Press, 2016; 257-271.
SCHÜTTRUMPF LH, et. al. Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1–3 cerebral metastases. Radiation Oncology, 2014; 9: 105.
SHEHATA MK, et. al. Stereotatic radiosurgery of 468 brain metastases ≤2 cm: implications for SRS dose and whole brain radiation therapy. International Journal of Radiation Oncology Biology Physics, 2004; 59(1): 87-93.
UP TO DATE. 2024. Stereotactic cranial radiosurgery. Disponível em: https ://www.uptodate.com/contents/stereotactic-cranial-radiosurgery?search=stereotactic%20radiotherapy%20&source=search_result&selectedTitle=1%7E150&usage_type=
default&display_rank=1#H2. Acessado em: 27 abr. 2024.